At the end of this procedure, a gene expression signature consisting of 11 genes (Fig 3, Dataset EV6) was selected as the shortest list providing the best agreement between observed and predicted CDK4 modification profiles in the three merged cohorts of breast tumors (84% agreement in the 56 tumors; all mismatches except one were between profiles H and L). This evidence concerns the gene CDK4 and breast neoplasm.